| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.11B | 60.56B | 59.15B | 58.58B | 54.40B | 52.43B |
| Gross Profit | 33.07B | 33.06B | 31.89B | 31.19B | 29.00B | 27.04B |
| EBITDA | 9.77B | 10.00B | 10.39B | 10.28B | 9.49B | 8.53B |
| Net Income | 2.77B | 2.95B | 3.13B | 2.70B | 2.56B | 2.29B |
Balance Sheet | ||||||
| Total Assets | 67.98B | 70.89B | 68.58B | 64.68B | 64.30B | 62.22B |
| Cash, Cash Equivalents and Short-Term Investments | 15.20B | 17.22B | 16.70B | 12.86B | 11.28B | 12.80B |
| Total Debt | 12.84B | 17.21B | 18.32B | 14.34B | 15.39B | 12.47B |
| Total Liabilities | 29.32B | 30.28B | 30.36B | 26.55B | 26.75B | 24.80B |
| Stockholders Equity | 38.67B | 40.61B | 38.21B | 38.12B | 37.54B | 37.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.71B | 3.06B | 4.13B | -568.00M | 3.67B |
| Operating Cash Flow | 0.00 | 7.45B | 7.83B | 8.93B | 6.01B | 10.41B |
| Investing Cash Flow | 0.00 | -4.93B | -5.62B | -6.69B | -7.78B | -7.00B |
| Financing Cash Flow | 0.00 | -2.50B | 633.00M | -2.66B | 316.00M | -1.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥190.81B | 17.98 | ― | 3.41% | 3.85% | 42.23% | |
76 Outperform | ¥173.98B | 11.81 | ― | 4.91% | 3.72% | 14.20% | |
75 Outperform | ¥43.58B | 13.60 | ― | 2.97% | 1.23% | -13.71% | |
66 Neutral | ¥9.05B | 3.19 | ― | 2.65% | 2.23% | ― | |
65 Neutral | ¥153.11B | 6.75 | ― | 2.20% | 12.74% | 24.57% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥3.39B | 10.54 | ― | 4.00% | 5.78% | 15.22% |